TissueScan, Kidney Cancer cDNA Array I

SKU
HKRT101
48 samples covering 7-normal, 21-Stage I, 6-II, 8-III, 6-IV. Available in 2, 5, 10 identical plates.
  $1,060.00
2 Weeks*
Specifications
Specifications
Product Data
TissueScan Type Cancer Specific
Array Name Kidney Cancer cDNA Array I
Clinical Info
Diagnosis Category Kidney Cancer
Tissue Kidney
Shipping Ambient
Description 48 samples covering 7-normal, 21-Stage I, 6-II, 8-III, 6-IV. Available in 2, 5, 10 identical plates.
Reviews
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources

file-alt Citations

Tr-KIT/c-KIT ratio in renal cell carcinoma
Ergün, Altay, Güneş et al
Mol. Biol. Rep. (2019)
AI Summary: OriGene's Kidney Cancer cDNA Array was used in this study to provide kidney tumor and normal tissue cDNA samples for gene expression analysis of tr-KIT and c-KIT in renal cell carcinoma.
Snippet: Materials and methods Study subjects In this study, Kidney Cancer cDNA Array (Origene Tech- nologies Inc., Rockville, MD, USA), a commercially avail- able, ready-to-use RCC cDNA panel for gene expression analysis using Real-Time PCR, was used [17]
Fluorocholine transport mediated by the organic cation transporter 2 (OCT2,SLC22A2): implication for imaging of kidney tumors
Visentin, Torozi, Gai et al
Drug Metab. Dispos. (2018)
AI Summary: OriGene contributed to this study by providing commercially available cDNA samples (TissueScan Kidney Cancer cDNA) used to assess SLC22A2 (OCT2) mRNA expression levels in kidney cancer tissues.
Snippet: characteristics are available in table 1. cDNA samples used for the assessment of SLC22A2 mRNA expression level was commercially available from Origene (Rockville, MD) (https://www.origene.com/catalog/tissues/tissuescan/hkrt102/tissuescan-kidney- cancer-cdna View as HTML
Annexin A2 in renal cell carcinoma: Expression, function, and prognostic significance
Yang, Hsu, Chao et al
Urol. Oncol. (2014)
Cited by 46
AI Summary: OriGene’s TissueScan cDNA array was used in this study to profile Annexin A2 (Anxa2) expression across various stages of renal cell carcinoma and normal tissues, enabling the authors to correlate Anxa2 expression with tumor progression and prognosis.
Snippet: profiling of Anxa2 in normal and tumor tissues, a commercial array was used that included cDNAs from 48 human RCC tissues (covering 9 normal, 10 stage I, 5 stage II, 13 stage III, and 11 stage IV specimens) normalized to β-actin (TissueScan, OriGene Technologies ... Cite SaveSaving
Showing 1-3 of 3 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products